Press release

Vi samler inn penger så 140 ME-syke kan reise til Haukeland sykehus, der de vil finne behandling og mekanismer bak sykdommen. Dette er en dugnad for å samle inn midler til en større randomisert, placebokontrollert studie (RCT) utledet fra Rituximabstudiene ved Haukeland sykehus. Studiene har vist de meste lovende resultatene for behandling av ME-syke per i dag. Studiene har ikke fått tilstrekkelig offentlig støtte.

We are fundraising a journey for 140 ME-sufferers to Haukeland Hospital, cancer ward. The scientist are searching for treatment and answers for the sick. This is a crowdfunding of Rituxan study at Haukeland Hospital by patient fundraising, which has showed the most promising results worldwide for ME/CFS-sufferers. The bigger RCT-study has not had sufficient economical support from the official healthcaresystem to continue their research.